Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Linear Methods for Efficient and Fast Separation of Two Sources Recorded with a Single Microphone.

Neural computation

Bhargava S, Blättler F, Kollmorgen S, Liu SC, Hahnloser RH.
PMID: 26313599
Neural Comput. 2015 Oct;27(10):2231-59. doi: 10.1162/NECO_a_00776. Epub 2015 Aug 27.

This letter addresses the problem of separating two speakers from a single microphone recording. Three linear methods are tested for source separation, all of which operate directly on sound spectrograms: (1) eigenmode analysis of covariance difference to identify spectro-temporal...

Cite
Bhargava S, Blättler F, Kollmorgen S, et al. Linear Methods for Efficient and Fast Separation of Two Sources Recorded with a Single Microphone. Neural Comput. 2015;27(10):2231-59doi: 10.1162/NECO_a_00776.
Bhargava, S., Blättler, F., Kollmorgen, S., Liu, S. C., & Hahnloser, R. H. (2015). Linear Methods for Efficient and Fast Separation of Two Sources Recorded with a Single Microphone. Neural computation, 27(10), 2231-59. https://doi.org/10.1162/NECO_a_00776
Bhargava, Saurabh, et al. "Linear Methods for Efficient and Fast Separation of Two Sources Recorded with a Single Microphone." Neural computation vol. 27,10 (2015): 2231-59. doi: https://doi.org/10.1162/NECO_a_00776
Bhargava S, Blättler F, Kollmorgen S, Liu SC, Hahnloser RH. Linear Methods for Efficient and Fast Separation of Two Sources Recorded with a Single Microphone. Neural Comput. 2015 Oct;27(10):2231-59. doi: 10.1162/NECO_a_00776. Epub 2015 Aug 27. PMID: 26313599.
Copy Download .nbib Format: NLM
Stationary transmission distribution of random spike trains by dynamical synapses.

Physical review. E, Statistical, nonlinear, and soft matter physics

Hahnloser RH.
PMID: 12636725
Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Feb;67(2):022901. doi: 10.1103/PhysRevE.67.022901. Epub 2003 Feb 10.

Many nonlinearities in neural media are strongly dependent on spike timing jitter and intrinsic dynamics of synaptic transmission. Here we are interested in the stationary density of evoked postsynaptic potentials transmitted by depressing synapses for Poisson spike trains of...

Cite
Hahnloser RH. Stationary transmission distribution of random spike trains by dynamical synapses. Phys Rev E Stat Nonlin Soft Matter Phys. 2003;67(2):022901doi: 10.1103/PhysRevE.67.022901.
Hahnloser, R. H. (2003). Stationary transmission distribution of random spike trains by dynamical synapses. Physical review. E, Statistical, nonlinear, and soft matter physics, 67(2), 022901. https://doi.org/10.1103/PhysRevE.67.022901
Hahnloser, Richard H R. "Stationary transmission distribution of random spike trains by dynamical synapses." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 67,2 (2003): 022901. doi: https://doi.org/10.1103/PhysRevE.67.022901
Hahnloser RH. Stationary transmission distribution of random spike trains by dynamical synapses. Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Feb;67(2):022901. doi: 10.1103/PhysRevE.67.022901. Epub 2003 Feb 10. PMID: 12636725.
Copy Download .nbib Format: NLM
[Critical observations on the therapy of heart infarct].

Medizinische Monatsschrift

HOHNLOSER E, BERGER H, SCHIMANSKIK.
PMID: 13908257
Med Monatsschr. 1962 Apr;16:237-41.

No abstract available.

Cite
HOHNLOSER E, BERGER H, SCHIMANSKIK. [Critical observations on the therapy of heart infarct]. Med Monatsschr. 1962;16:237-41
HOHNLOSER, E., BERGER, H., & SCHIMANSKIK. (1962). [Critical observations on the therapy of heart infarct]. Medizinische Monatsschrift, 16237-41.
HOHNLOSER, E, et al. "[Critical observations on the therapy of heart infarct]." Medizinische Monatsschrift vol. 16 (1962): 237-41.
HOHNLOSER E, BERGER H, SCHIMANSKIK. [Critical observations on the therapy of heart infarct]. Med Monatsschr. 1962 Apr;16:237-41. German. PMID: 13908257.
Copy Download .nbib Format: NLM
Syncope on exertion in a young male.

HeartRhythm case reports

Erath JW, Puntmann VO, Chavakis E, Hohnloser SH.
PMID: 30023282
HeartRhythm Case Rep. 2018 Apr 22;4(7):324-327. doi: 10.1016/j.hrcr.2018.04.005. eCollection 2018 Jul.

No abstract available.

Cite
Erath JW, Puntmann VO, Chavakis E, et al. Syncope on exertion in a young male. HeartRhythm Case Rep. 2018;4(7):324-327doi: 10.1016/j.hrcr.2018.04.005.
Erath, J. W., Puntmann, V. O., Chavakis, E., & Hohnloser, S. H. (2018). Syncope on exertion in a young male. HeartRhythm case reports, 4(7), 324-327. https://doi.org/10.1016/j.hrcr.2018.04.005
Erath, Julia W, et al. "Syncope on exertion in a young male." HeartRhythm case reports vol. 4,7 (2018): 324-327. doi: https://doi.org/10.1016/j.hrcr.2018.04.005
Erath JW, Puntmann VO, Chavakis E, Hohnloser SH. Syncope on exertion in a young male. HeartRhythm Case Rep. 2018 Apr 22;4(7):324-327. doi: 10.1016/j.hrcr.2018.04.005. eCollection 2018 Jul. PMID: 30023282; PMCID: PMC6050438.
Copy Download .nbib Format: NLM
Projection neuron circuits resolved using correlative array tomography.

Frontiers in neuroscience

Oberti D, Kirschmann MA, Hahnloser RH.
PMID: 21519397
Front Neurosci. 2011 Apr 12;5:50. doi: 10.3389/fnins.2011.00050. eCollection 2011.

Assessment of three-dimensional morphological structure and synaptic connectivity is essential for a comprehensive understanding of neural processes controlling behavior. Different microscopy approaches have been proposed based on light microcopy (LM), electron microscopy (EM), or a combination of both. Correlative...

Cite
Oberti D, Kirschmann MA, Hahnloser RH. Projection neuron circuits resolved using correlative array tomography. Front Neurosci. 2011;5:50doi: 10.3389/fnins.2011.00050.
Oberti, D., Kirschmann, M. A., & Hahnloser, R. H. (2011). Projection neuron circuits resolved using correlative array tomography. Frontiers in neuroscience, 550. https://doi.org/10.3389/fnins.2011.00050
Oberti, Daniele, et al. "Projection neuron circuits resolved using correlative array tomography." Frontiers in neuroscience vol. 5 (2011): 50. doi: https://doi.org/10.3389/fnins.2011.00050
Oberti D, Kirschmann MA, Hahnloser RH. Projection neuron circuits resolved using correlative array tomography. Front Neurosci. 2011 Apr 12;5:50. doi: 10.3389/fnins.2011.00050. eCollection 2011. PMID: 21519397; PMCID: PMC3080615.
Copy Download .nbib Format: NLM
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.

Cardiovascular research

Benz AP, Healey JS, Chin A, Commerford P, Marsden T, Karthikeyan G, McIntyre WF, Wong JA, Damasceno A, Hohnloser SH, Oldgren J, Wallentin L, Ezekowitz MD, Eikelboom JW, Yusuf S, Connolly SJ.
PMID: 33386845
Cardiovasc Res. 2022 Jan 07;118(1):295-304. doi: 10.1093/cvr/cvaa344.

AIMS: Patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), especially mitral stenosis, are assumed to be at high risk of stroke, irrespective of other factors. We aimed to re-evaluate stroke risk factors in a contemporary cohort of...

Cite
Benz AP, Healey JS, Chin A, et al. Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease. Cardiovasc Res. 2022;118(1):295-304doi: 10.1093/cvr/cvaa344.
Benz, A. P., Healey, J. S., Chin, A., Commerford, P., Marsden, T., Karthikeyan, G., McIntyre, W. F., Wong, J. A., Damasceno, A., Hohnloser, S. H., Oldgren, J., Wallentin, L., Ezekowitz, M. D., Eikelboom, J. W., Yusuf, S., & Connolly, S. J. (2022). Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease. Cardiovascular research, 118(1), 295-304. https://doi.org/10.1093/cvr/cvaa344
Benz, Alexander P, et al. "Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease." Cardiovascular research vol. 118,1 (2022): 295-304. doi: https://doi.org/10.1093/cvr/cvaa344
Benz AP, Healey JS, Chin A, Commerford P, Marsden T, Karthikeyan G, McIntyre WF, Wong JA, Damasceno A, Hohnloser SH, Oldgren J, Wallentin L, Ezekowitz MD, Eikelboom JW, Yusuf S, Connolly SJ. Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease. Cardiovasc Res. 2022 Jan 07;118(1):295-304. doi: 10.1093/cvr/cvaa344. PMID: 33386845.
Copy Download .nbib Format: NLM
Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of AT Dispersion to Predict Proarrhythmia.

Journal of cardiovascular pharmacology and therapeutics

van de Loo A, Klingenheben T, Hohnloser SH.
PMID: 10684402
J Cardiovasc Pharmacol Ther. 1996 Jan;1(1):75-78. doi: 10.1177/107424849600100111.

BACKGROUND: Polymorphic ventricular tachycardia of the torsade de pointes type represents, potentially, the most dangerous side effect of antiarrhythmic drugs that prolong ventricular repolarization. Much effort has been devoted to the identification of the degree of drug-associated QT prolongation...

Cite
van de Loo A, Klingenheben T, Hohnloser SH. Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of AT Dispersion to Predict Proarrhythmia. J Cardiovasc Pharmacol Ther. 1996;1(1):75-78doi: 10.1177/107424849600100111.
van de Loo A, Klingenheben, T., & Hohnloser, S. H. (1996). Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of AT Dispersion to Predict Proarrhythmia. Journal of cardiovascular pharmacology and therapeutics, 1(1), 75-78. https://doi.org/10.1177/107424849600100111
van de Loo A, et al. "Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of AT Dispersion to Predict Proarrhythmia." Journal of cardiovascular pharmacology and therapeutics vol. 1,1 (1996): 75-78. doi: https://doi.org/10.1177/107424849600100111
van de Loo A, Klingenheben T, Hohnloser SH. Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of AT Dispersion to Predict Proarrhythmia. J Cardiovasc Pharmacol Ther. 1996 Jan;1(1):75-78. doi: 10.1177/107424849600100111. PMID: 10684402.
Copy Download .nbib Format: NLM
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial.

TH open : companion journal to thrombosis and haemostasis

Kirchhof P, Ezekowitz MD, Purmah Y, Schiffer S, Meng IL, Camm AJ, Hohnloser SH, Schulz A, Wosnitza M, Cappato R.
PMID: 31984306
TH Open. 2020 Jan 23;4(1):e20-e32. doi: 10.1055/s-0040-1701206. eCollection 2020 Jan.

No abstract available.

Cite
Kirchhof P, Ezekowitz MD, Purmah Y, et al. Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. TH Open. 2020;4(1):e20-e32doi: 10.1055/s-0040-1701206.
Kirchhof, P., Ezekowitz, M. D., Purmah, Y., Schiffer, S., Meng, I. L., Camm, A. J., Hohnloser, S. H., Schulz, A., Wosnitza, M., & Cappato, R. (2020). Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. TH open : companion journal to thrombosis and haemostasis, 4(1), e20-e32. https://doi.org/10.1055/s-0040-1701206
Kirchhof, Paulus, et al. "Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial." TH open : companion journal to thrombosis and haemostasis vol. 4,1 (2020): e20-e32. doi: https://doi.org/10.1055/s-0040-1701206
Kirchhof P, Ezekowitz MD, Purmah Y, Schiffer S, Meng IL, Camm AJ, Hohnloser SH, Schulz A, Wosnitza M, Cappato R. Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. TH Open. 2020 Jan 23;4(1):e20-e32. doi: 10.1055/s-0040-1701206. eCollection 2020 Jan. PMID: 31984306; PMCID: PMC6978177.
Copy Download .nbib Format: NLM
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI.

European heart journal. Cardiovascular pharmacotherapy

Costa F, Valgimigli M, Steg PG, Bhatt DL, Hohnloser SH, Ten Berg JM, Miede C, Nordaby M, Lip GYH, Oldgren J, Cannon CP.
PMID: 33258897
Eur Heart J Cardiovasc Pharmacother. 2020 Dec 01; doi: 10.1093/ehjcvp/pvaa135. Epub 2020 Dec 01.

AIMS: Patients with atrial fibrillation undergoing coronary intervention are at higher bleeding risk due to the concomitant need for oral anticoagulation and antiplatelet therapy. The RE-DUAL PCI trial demonstrated better safety with dual antithrombotic therapy (DAT: dabigatran 110 or...

Cite
Costa F, Valgimigli M, Steg PG, et al. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. Eur Heart J Cardiovasc Pharmacother. 2020;doi: 10.1093/ehjcvp/pvaa135.
Costa, F., Valgimigli, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Ten Berg, J. M., Miede, C., Nordaby, M., Lip, G. Y. H., Oldgren, J., & Cannon, C. P. (2020). Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvaa135
Costa, Francesco, et al. "Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI." European heart journal. Cardiovascular pharmacotherapy vol. (2020). doi: https://doi.org/10.1093/ehjcvp/pvaa135
Costa F, Valgimigli M, Steg PG, Bhatt DL, Hohnloser SH, Ten Berg JM, Miede C, Nordaby M, Lip GYH, Oldgren J, Cannon CP. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. Eur Heart J Cardiovasc Pharmacother. 2020 Dec 01; doi: 10.1093/ehjcvp/pvaa135. Epub 2020 Dec 01. PMID: 33258897.
Copy Download .nbib Format: NLM
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study.

European heart journal. Quality of care & clinical outcomes

Halvorsen S, Johnsen SP, Madsen M, Linder M, Sulo G, Ghanima W, Gislason G, Hohnloser SH, Jenkins A, Al-Khalili F, Tell GS, Ehrenstein V.
PMID: 34244745
Eur Heart J Qual Care Clin Outcomes. 2021 Jul 09; doi: 10.1093/ehjqcco/qcab048. Epub 2021 Jul 09.

AIMS: Using Scandinavian population-based registries, we assessed risk of stroke/systemic embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared with warfarin in oral anticoagulation-naïve patients with atrial fibrillation (AF).METHODS AND RESULTS: This historical cohort study included 219,545...

Cite
Halvorsen S, Johnsen SP, Madsen M, et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study. Eur Heart J Qual Care Clin Outcomes. 2021;doi: 10.1093/ehjqcco/qcab048.
Halvorsen, S., Johnsen, S. P., Madsen, M., Linder, M., Sulo, G., Ghanima, W., Gislason, G., Hohnloser, S. H., Jenkins, A., Al-Khalili, F., Tell, G. S., & Ehrenstein, V. (2021). Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study. European heart journal. Quality of care & clinical outcomes, . https://doi.org/10.1093/ehjqcco/qcab048
Halvorsen, Sigrun, et al. "Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study." European heart journal. Quality of care & clinical outcomes vol. (2021). doi: https://doi.org/10.1093/ehjqcco/qcab048
Halvorsen S, Johnsen SP, Madsen M, Linder M, Sulo G, Ghanima W, Gislason G, Hohnloser SH, Jenkins A, Al-Khalili F, Tell GS, Ehrenstein V. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study. Eur Heart J Qual Care Clin Outcomes. 2021 Jul 09; doi: 10.1093/ehjqcco/qcab048. Epub 2021 Jul 09. PMID: 34244745.
Copy Download .nbib Format: NLM
Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Curtis AB, Zeitler EP, Malik A, Bogard A, Bhattacharyya N, Stewart J, Hohnloser SH.
PMID: 34374766
Europace. 2021 Aug 10; doi: 10.1093/europace/euab208. Epub 2021 Aug 10.

AIMS: Age and sex may impact the efficacy of antiarrhythmic drugs on cardiovascular outcomes and arrhythmia recurrences in patients with atrial fibrillation (AF). We report on a post hoc analysis of the ATHENA study (NCT00174785), which examined cardiovascular outcomes...

Cite
Curtis AB, Zeitler EP, Malik A, et al. Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter. Europace. 2021;doi: 10.1093/europace/euab208.
Curtis, A. B., Zeitler, E. P., Malik, A., Bogard, A., Bhattacharyya, N., Stewart, J., & Hohnloser, S. H. (2021). Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, . https://doi.org/10.1093/europace/euab208
Curtis, Anne B, et al. "Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter." Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology vol. (2021). doi: https://doi.org/10.1093/europace/euab208
Curtis AB, Zeitler EP, Malik A, Bogard A, Bhattacharyya N, Stewart J, Hohnloser SH. Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter. Europace. 2021 Aug 10; doi: 10.1093/europace/euab208. Epub 2021 Aug 10. PMID: 34374766.
Copy Download .nbib Format: NLM
Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial.

European heart journal. Cardiovascular pharmacotherapy

Vamos M, Oldgren J, Nam GB, Lip GYH, Calkins H, Zhu J, Ueng KC, Ludwigs U, Wieloch M, Stewart J, Hohnloser SH, Gökçearslan Ş, Mumcu FK, Haşlaman T.
PMID: 34958366
Eur Heart J Cardiovasc Pharmacother. 2021 Dec 27; doi: 10.1093/ehjcvp/pvab090. Epub 2021 Dec 27.

AIMS: Use of antiarrhythmic drugs (AADs) in patients with chronic kidney disease (CKD) is challenging owing to issues with renal clearance, drug accumulation and increased proarrhythmic risks. Because CKD is a common comorbidity in patients with atrial fibrillation/atrial flutter...

Cite
Vamos M, Oldgren J, Nam GB, et al. Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial. Eur Heart J Cardiovasc Pharmacother. 2021;doi: 10.1093/ehjcvp/pvab090.
Vamos, M., Oldgren, J., Nam, G. B., Lip, G. Y. H., Calkins, H., Zhu, J., Ueng, K. C., Ludwigs, U., Wieloch, M., Stewart, J., Hohnloser, S. H., Gökçearslan, �. �., Mumcu, F. K., & Haşlaman, T. (2021). Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvab090
Vamos, Mate, et al. "Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial." European heart journal. Cardiovascular pharmacotherapy vol. (2021). doi: https://doi.org/10.1093/ehjcvp/pvab090
Vamos M, Oldgren J, Nam GB, Lip GYH, Calkins H, Zhu J, Ueng KC, Ludwigs U, Wieloch M, Stewart J, Hohnloser SH, Gökçearslan Ş, Mumcu FK, Haşlaman T. Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial. Eur Heart J Cardiovasc Pharmacother. 2021 Dec 27; doi: 10.1093/ehjcvp/pvab090. Epub 2021 Dec 27. PMID: 34958366.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries